July 16 (Reuters) - Prediction market platform Kalshi will start taking bets on the outcomes of clinical trials and FDA ...

FDA sets PDUFA target action date of May 1, 2027NEW YORK, July 15, 2026 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a ...

The president talked about election security less than four months before the midterms, where Republicans are seeking to ...

FDA sets PDUFA target action date of May 1, 2027 NEW YORK, July 15, 2026 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of ...

You've got the sniffles, and your nose is running like a faucet. The tissues feel like sandpaper. Many Australians reach for ...

Detailed price information for Jupiter Neurosciences Inc (JUNS-Q) from The Globe and Mail including charting and trades.

Can we trust the federal government and its ever-changing nutrition guidelines, to teach us how and what to cook?

Defense Secretary Pete Hegseth said Wednesday that troops ages 30 and older will be subject to annual testosterone screenings ...

Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule ...

Biogen touted an “unprecedented” drop in tau in a Phase 2 trial, backing the company’s decision to take diranersen to Phase 3 despite a missed primary endpoint and seemingly supporting the anti-tau ...

The FDA intends to hold an advisory committee meeting on SYD-101, which is being investigated for pediatric myopia but was ...

That panel will meet to weigh whether the agency should allow Americans to have broader access to seven injectable peptides ...